CPB
39
4
SE
43
3
IBM
62
-3
KMI
53
-6
DGX
36
-4
AME
66
-3
ECL
52
-2
CVX
23
-2
SLB
42
-4
O
35
-7
CINF
63
-3
CSX
48
-2
ORCL
28
3
FLS
50
-5
PCG
67
-2
TJX
64
-2
CMCSA
53
7
RSG
50
-4
SPG
55
-3
FCX
72
-2
CPB
39
4
SE
43
3
IBM
62
-3
KMI
53
-6
DGX
36
-4
AME
66
-3
ECL
52
-2
CVX
23
-2
SLB
42
-4
O
35
-7
CINF
63
-3
CSX
48
-2
ORCL
28
3
FLS
50
-5
PCG
67
-2
TJX
64
-2
CMCSA
53
7
RSG
50
-4
SPG
55
-3
FCX
72
-2
Financhill
Back

Putnam Focused Large Cap Growth ETF Vs. Nektar Therapeutics Industry Stock Comparison

Buy
58

PGRO
Putnam Focused Large Cap Growth ETF

Last Price:
$43.49
Seasonality Move:
7.26%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$45.42
Seasonality Move:
11.58%
Buy
58
Putnam Focused Large Cap Growth ETF (PGRO) is a Buy

Is Putnam Focused Large Cap Growth ETF a Buy, Sell or Hold?

  • The current Putnam Focused Large Cap Growth ETF [PGRO] share price is $44.34. The Score for PGRO is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • PGRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PGRO Stock Price Chart

What is Putnam Focused Large Cap Growth ETF's stock price today?

  • The Putnam Focused Large Cap Growth ETF share price today is $44.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PGRO is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

PGRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 45.33 Sell
Chaikin Money Flow: 3585 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.73 - 61.13) Sell
Bollinger Bands (100): (33.63 - 62.73) Buy

PGRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.87 Sell
20-day SMA: 44.57 Sell
50-day SMA: 44.75 Sell
200-day SMA: 40.72 Buy
8-day EMA: 44.68 Sell
20-day EMA: 44.74 Sell
50-day EMA: 44.54 Sell
200-day EMA: 41.76 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Putnam Focused Large Cap Growth ETF Earnings Growth & PGRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Putnam Focused Large Cap Growth ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):